Dexcom Announces Upcoming Conference Presentations
24 February 2023 - 1:00AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that management will
present an update on the company at the following upcoming investor
conferences:
- Sean Christensen, Vice President, Finance and Investor
Relations, will present on behalf of the company at the Citi 2023
Healthcare Services, Medtech, Tools & HCIT Conference on
Wednesday, March 1, 2023 at 2:45pm (EST).
- Jereme Sylvain, Executive Vice President and Chief Financial
Officer, will present on behalf of the company at the Raymond James
44th Annual Institutional Investors Conference on Tuesday, March 7,
2023 at 3:25pm (EST).
Links to the webcast will be available on the Dexcom Investor
Relations website at investors.dexcom.com and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of
diabetes through innovative continuous glucose monitoring (CGM)
systems. Headquartered in San Diego, California, and with
operations across Europe and select parts of Asia/Oceania, Dexcom
has emerged as a leader of diabetes care technology. By listening
to the needs of users, caregivers, and providers, Dexcom simplifies
and improves diabetes management around the world. For more
information about Dexcom CGM, visit www.dexcom.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230223005174/en/
DexCom, Inc. Sean Christensen Vice President – Finance
and Investor Relations investor-relations@dexcom.com (858)
200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2024 to May 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From May 2023 to May 2024